Alexion AstraZeneca Rare Disease

Boston,  MA 
United States
  • Booth: 1022

Please stop by to learn about low ALP and hypophosphatasia.

Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.


For Technical Support with this webpage, please contact support